Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Preferred Stock Liabilities (2024 - 2026)

Updated

Seaport Therapeutics' Preferred Stock Liabilities was $325.33 million in Q1 2026, unchanged from $325.33 million a year earlier and unchanged from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Preferred Stock Liabilities (2024 - 2026) Analysis & Trends

From Q4 2024 onward, Seaport Therapeutics has reported Preferred Stock Liabilities for 6 quarters.

  • In earlier years, Preferred Stock Liabilities was $325.33 million in FY2024.
  • Per Business Quant data, SPTX's Preferred Stock Liabilities in the three quarters before Q1 2026 was $325.33 million (Q4 2025), $325.33 million (Q3 2025) and $325.33 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 325.33 Mn
Dec 31, 2025 325.33 Mn
Sep 30, 2025 325.33 Mn
Jun 30, 2025 325.33 Mn
Mar 31, 2025 325.33 Mn
Dec 31, 2024 325.33 Mn
API Access

Seaport Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SPTX&period=max&api_key=YOUR_API_KEY